Cumberland Pharmaceuticals (CPIX) Integrates Commercial Business with Apotex

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) is one of the 10 Best Day Trading Penny Stocks to Buy.

On April 23, 2026, Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) agreed to sell its branded pharmaceutical portfolio to an affiliate of Apotex for $100M in cash, with the companies planning to form a specialty medicines platform. The transaction is subject to shareholder approval. Cumberland will retain its pipeline and its majority stake in Cumberland Emerging Technologies. The company continues to develop ifetroban and has reported Phase II results in cardiomyopathy associated with Duchenne muscular dystrophy, with FDA discussions ongoing. The program holds Orphan Drug, Rare Pediatric Disease, and Fast Track designations.

Cumberland Pharmaceuticals (CPIX) Integrates Commercial Business with Apotex

On April 16, 2026, Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) received FDA approval to expand the indication for Caldolor to include postoperative pain. The product is indicated for adult and pediatric patients ages 3 months and older for mild to moderate pain, moderate to severe pain as an adjunct to opioid analgesics, and the reduction of fever.

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) acquires, develops, and commercializes prescription pharmaceutical products.

While we acknowledge the risk and potential of CPIX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CPIX and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.